190 related articles for article (PubMed ID: 36681530)
1. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
[TBL] [Abstract][Full Text] [Related]
2. TriGuard
Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
[TBL] [Abstract][Full Text] [Related]
3. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
[TBL] [Abstract][Full Text] [Related]
4. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
[TBL] [Abstract][Full Text] [Related]
5. Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
Kapadia SR; Makkar R; Leon M; Abdel-Wahab M; Waggoner T; Massberg S; Rottbauer W; Horr S; Sondergaard L; Karha J; Gooley R; Satler L; Stoler RC; Messé SR; Baron SJ; Seeger J; Kodali S; Krishnaswamy A; Thourani VH; Harrington K; Pocock S; Modolo R; Allocco DJ; Meredith IT; Linke A;
N Engl J Med; 2022 Oct; 387(14):1253-1263. PubMed ID: 36121045
[TBL] [Abstract][Full Text] [Related]
6. Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
Isogai T; Vanguru HR; Krishnaswamy A; Agrawal A; Spilias N; Shekhar S; Saad AM; Verma BR; Puri R; Reed GW; Popović ZB; Unai S; Yun JJ; Uchino K; Kapadia SR
Catheter Cardiovasc Interv; 2022 Nov; 100(5):810-820. PubMed ID: 35916117
[TBL] [Abstract][Full Text] [Related]
7. Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.
Wolfrum M; Handerer IJ; Moccetti F; Schmeisser A; Braun-Dullaeus RC; Toggweiler S
BMC Cardiovasc Disord; 2023 Jun; 23(1):306. PubMed ID: 37330463
[TBL] [Abstract][Full Text] [Related]
8. Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II.
Nazif TM; Moses J; Sharma R; Dhoble A; Rovin J; Brown D; Horwitz P; Makkar R; Stoler R; Forrest J; Messé S; Dickerman S; Brennan J; Zivadinov R; Dwyer MG; Lansky AJ;
JACC Cardiovasc Interv; 2021 Mar; 14(5):515-527. PubMed ID: 33663779
[TBL] [Abstract][Full Text] [Related]
9. Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis.
Kaur A; Dhaliwal AS; Sohal S; Gwon Y; Gupta S; Bhatia K; Dominguez AC; Basman C; Tamis-Holland J
J Am Heart Assoc; 2024 Feb; 13(3):e030587. PubMed ID: 38240252
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
Ndunda PM; Vindhyal MR; Muutu TM; Fanari Z
Cardiovasc Revasc Med; 2020 Jun; 21(6):717-722. PubMed ID: 31175048
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Cerebral Embolic Protection Devices on Characteristics and Outcomes of Stroke Complicating TAVR.
Levi A; Linder M; Seiffert M; Witberg G; Pilgrim T; Tomii D; Barkan YT; Van Mieghem NM; Adrichem R; Codner P; Hildick-Smith D; Arunothayaraj S; Perl L; Finkelstein A; Loewenstein I; De Backer O; Barnea R; Tarantini G; Fovino LN; Vaknin-Assa H; Mylotte D; Wagener M; Webb JG; Akodad M; Colombo A; Mangieri A; Latib A; Kargoli F; Giannini F; Ielasi A; Søndergaard L; Aviram I; Lerman TT; Kheifets M; Auriel E; Kornowski R;
JACC Cardiovasc Interv; 2024 Mar; 17(5):666-677. PubMed ID: 38479966
[TBL] [Abstract][Full Text] [Related]
12. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
[TBL] [Abstract][Full Text] [Related]
13. Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art.
Deveci OS; Okutucu S; Fatihoglu SG; Oto A
Acta Cardiol; 2022 May; 77(3):196-203. PubMed ID: 33827380
[TBL] [Abstract][Full Text] [Related]
14. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
[TBL] [Abstract][Full Text] [Related]
16. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
[TBL] [Abstract][Full Text] [Related]
17. Cerebral embolic protection systems for transcatheter aortic valve replacement.
Gasior T; Mangner N; Bijoch J; Wojakowski W
J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement.
Yashima F; Briasoulis A; Kuno T; Noguchi M; Ahmad H; Zaid S; Goldberg JB; Malik AH; Tang GHL
Cardiovasc Revasc Med; 2022 Mar; 36():9-13. PubMed ID: 34024747
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Embolic Protection Devices for Transcatheter Aortic Valve Replacement: Review of the Literature and Future Perspectives.
Ng S; Cunningham T; Vavalle JP
Curr Cardiol Rep; 2024 May; 26(5):339-347. PubMed ID: 38472629
[TBL] [Abstract][Full Text] [Related]
20. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
